Hauptseite
Ausbildung

Design and Industrial Manufacture of Medicines

Daten

Offizielle Daten in der Fachveröffentlichung für das folgende akademische Jahr: 2021-2022

Lehrbeauftragte/r

  • Dr. Szilárd PÁL

    assistant professor,
    Institute of Pharmaceutical Technology and Biopharmacy

Semesterwochenstunden

Vorlesungen: 28

Praktika: 0

Seminare: 0

Insgesamt: 28

Fachangaben

  • Kode des Kurses: OPE-SHK-T
  • 2 kredit
  • Pharmacy
  • Elective modul
  • autumn
Voraussetzungen:

OPG-BFR-T completed , OPG-C2E-T completed

Zahl der Kursteilnehmer für den Kurs:

min. 1 – max. 50

Thematik

During the course, the process of the design of modified drug delivery systems is acquired by the students based on the theory and practice of biopharmaceutical including examinations of dosage forms. The course consists of theoretical lectures and seminars.

Vorlesungen

  • 1. Floating drug delivery, Targeted Drug Delivery Systems - Dr. Pál Szilárd
  • 2. Floating drug delivery, Targeted Drug Delivery Systems - Dr. Pál Szilárd
  • 3. Floating drug delivery, Targeted Drug Delivery Systems - Dr. Pál Szilárd
  • 4. Floating drug delivery, Targeted Drug Delivery Systems - Dr. Pál Szilárd
  • 5. Introduction of modified drug delivery - Dr. Kása Péter
  • 6. Introduction of modified drug delivery - Dr. Kása Péter
  • 7. Introduction of modified drug delivery - Dr. Kása Péter
  • 8. Introduction of modified drug delivery - Dr. Kása Péter
  • 9. Targeted Drug Delivery Systems - Dr. Secenji Aleksandar
  • 10. Targeted Drug Delivery Systems - Dr. Secenji Aleksandar
  • 11. Targeted Drug Delivery Systems - Dr. Pál Szilárd
  • 12. Targeted Drug Delivery Systems - Dr. Pál Szilárd
  • 13. Pulsative Drug Delivery Systems - Dr. Pál Szilárd
  • 14. Pulsative Drug Delivery Systems - Dr. Pál Szilárd
  • 15. Pulsative Drug Delivery Systems - Dr. Pál Szilárd
  • 16. Pulsative Drug Delivery Systems - Dr. Pál Szilárd
  • 17. Dissolution, lecture and practice -
  • 18. Dissolution, lecture and practice -
  • 19. Dissolution, lecture and practice - Dr. Pál Szilárd
  • 20. Dissolution, lecture and practice - Dr. Pál Szilárd
  • 21. From molecule to the preparition - Dr. Kása Péter
  • 22. From molecule to the preparition - Dr. Kása Péter
  • 23. From molecule to the preparition - Dr. Pál Szilárd
  • 24. From molecule to the preparition - Dr. Pál Szilárd
  • 25. 3D printing in pharmaceutical technology -
  • 26. 3D printing in pharmaceutical technology -
  • 27. Assessment - Dr. Pál Szilárd
  • 28. Assessment - Dr. Pál Szilárd

Praktika

Seminare

Materialien zum Aneignen des Lehrstoffes

Obligatorische Literatur

Vom Institut veröffentlichter Lehrstoff

Skript

Empfohlene Literatur

Leon Shargel, A. B.C. Yu, Stamford: Applied Biopharmaceutics and Pharmacokinetics
Susanna Wu-Pong, Yon Rojanasakul: Biopharmaceutical Drug Design and Development, Humana Press
Gilbert S. Banker, Christopher T. Rhodes: Modern Pharmaceutics, Marcel Dekker Inc., New York- Basel
Michael J. Rathbone, Michael S. Roberts: Modified-Release Drug Delivery Technology, Informa Healthcare
Michael E. Aulton: The Design and Manufacture of Medicines, Churchill Livingstone

Voraussetzung zum Absolvieren des Semesters

Maximum of 25 % absence allowed

Semesteranforderungen

Students have to write an end-semester assessment from the lectures at acceptance level of 60%.

Möglichkeiten zur Nachholung der Fehlzeiten

Students must fulfil requirements determined by the Code of Studies and Examinations. Student has make up for the missed lectures and work reports.

Prüfungsfragen

Students can get the test topics in the institute or download the from website of the institute.

Prüfer

Praktika, Seminarleiter/innen

  • Dr. Kása Péter
  • Dr. Pál Szilárd
  • Dr. Secenji Aleksandar
Rólunk